Zota Healthcare
Zota Healthcare Performance
Day Range
- Low 386.9
- High 405.5
52 Week Range
- Low 251
- High 495
- Open Price394
- Previous Close390.7
- Volume27139
Start SIP in Zota Healthcare
Start SIPZota Healthcare Investment Rating
-
Master Rating:
-
Zota Health Care Ltd has an operating revenue of Rs. 149.41 Cr. on a trailing 12-month basis. An annual revenue growth of 7% is good, Pre-tax margin of -3% needs improvement, ROE of -7% is poor and needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 50DMA and around 16% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 4 which is a POOR score indicating inconsistency in earnings, a RS Rating of 60 which is FAIR indicating the recent price performance, Buyer Demand at C- which is evident from recent supply seen, Group Rank of 99 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Institutional holding has remained stable in the last reported quarter. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 35 | 36 | 34 | 39 | 29 | 32 |
| Operating Expenses Qtr Cr | 35 | 36 | 34 | 33 | 27 | 31 |
| Operating Profit Qtr Cr | 1 | 1 | 0 | 5 | 2 | 0 |
| Depreciation Qtr Cr | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Qtr Cr | 0 | 0 | 0 | 1 | 1 | 0 |
| Net Profit Qtr Cr | 0 | 1 | 0 | 4 | 1 | 0 |
Zota Healthcare Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 7
- Bearish Moving Average
- ___
- 9
- 20 Day
- ₹412.16
- 50 Day
- ₹408.25
- 100 Day
- ₹383.17
- 200 Day
- ₹352.18
- 20 Day
- ₹417.83
- 50 Day
- ₹419.56
- 100 Day
- ₹371.31
- 200 Day
- ₹336.25
Zota Healthcare Resistance and Support
| Resistance | |
|---|---|
| First Resistance | ₹405.87 |
| Second Resistance | ₹414.99 |
| Third Resistance | ₹424.47 |
| RSI | 42.34 |
| MFI | 31.52 |
| MACD Single Line | -4.74 |
| MACD | -8.98 |
| Support | |
|---|---|
| First Resistance | ₹387.27 |
| Second Resistance | ₹377.79 |
| Third Resistance | ₹368.67 |
Zota Healthcare Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 27,139 | 1,432,668 | 52.79 |
| Week | 25,278 | 1,365,996 | 54.04 |
| 1 Month | 38,982 | 2,063,295 | 52.93 |
| 6 Month | 48,139 | 2,717,936 | 56.46 |
Zota Healthcare Result Highlights
Zota Healthcare Synopsis
NSE-Medical-Diversified
Zota Healthcare is involved in the business activities of Wholesale of pharmaceutical and medical goods. Company’s Total Operating Revenue is Rs. 138.37 Cr. and Equity Capital is Rs. 25.16 Cr. for the Year ended 31/03/2023. Zota Healthcare Ltd. is a Public Limited Listed company incorporated on 12/07/2000 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24231GJ2000PLC038352 and registration number is 038352.| Market Cap | 1,025 |
| Sales | 144 |
| Shares in Float | 0.88 |
| No of funds | 1 |
| Yield | 0.4 |
| Book Value | 10.52 |
| U/D Vol ratio | 1.1 |
| LTDebt / Equity | |
| Alpha | 0.06 |
| Beta | 0.73 |
Zota Healthcare
| Owner Name | Jul-23 | Jun-23 | Mar-23 | Dec-22 |
|---|---|---|---|---|
| Promoters | 66.16% | 68.12% | 68.12% | 68.12% |
| Mutual Funds | ||||
| Insurance Companies | ||||
| Foreign Portfolio Investors | 0.04% | |||
| Financial Institutions/ Banks | ||||
| Individual Investors | 22.16% | 20.57% | 20.56% | 21.21% |
| Others | 11.64% | 11.31% | 11.32% | 10.67% |
Zota Healthcare Management
| Name | Designation |
|---|---|
| Mr. Ketankumar Chandulal Zota | Non Executive Chairman |
| Mr. Moxesh Ketanbhai Zota | Managing Director |
| Mr. Kamlesh Rajnikant Zota | Whole Time Director |
| Mr. Himanshu Muktilal Zota | Whole Time Director |
| Mr. Manukant Chandulal Zota | Whole Time Director |
| Dr.(Mrs.) Varsaben Gaurang Mehta | Ind. Non-Executive Director |
| Mrs. Jaysheeben Nileshkumar Mehta | Ind. Non-Executive Director |
| Dr. Dhiren Prafulbhai Shah | Ind. Non-Executive Director |
| Ms. Bhumi Maulik Doshi | Ind. Non-Executive Director |
| CA. Vitrag Sureshkumar Modi | Ind. Non-Executive Director |
Zota Healthcare Forecast
Price Estimates
Zota Healthcare Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2023-05-30 | Audited Results & Dividend | |
| 2023-02-13 | Quarterly Results | |
| 2023-01-11 | Others | Other business matters final dividend at the rate of 10 % i.e. Re. 1 per share for the financial year 2018-19 |
| 2022-11-14 | Quarterly Results | |
| 2022-08-13 | Quarterly Results |
- Company Name
- CMP
- Chg(%)
- IndusInd Bank
- 1453
- 2.9
- Maruti Suzuki
- 10535
- 2.4
- St Bk of India
- 598
- 1.7
- M & M
- 1607
- 1.5
- Bajaj Finserv
- 1544
- 1.1
- Company Name
- CMP
- Chg(%)
Zota Healthcare FAQs
What is Share Price of Zota Healthcare ?
Zota Healthcare share price is ₹396 As on 22 September, 2023 | 23:04
What is the Market Cap of Zota Healthcare ?
The Market Cap of Zota Healthcare is ₹1025.5 Cr As on 22 September, 2023 | 23:04
What is the P/E ratio of Zota Healthcare ?
The P/E ratio of Zota Healthcare is -131.6 As on 22 September, 2023 | 23:04
What is the PB ratio of Zota Healthcare ?
The PB ratio of Zota Healthcare is 12.8 As on 22 September, 2023 | 23:04